Our study is supported by previous observational and MR studies [4, 13–15, 42, 43] that genetic liability to T2D and FI likely increases the risk of liver steatosis and related biomarkers (e.g., ALT and PDFF), while liability to T2D appears to also increase the risk of liver cirrhosis. This evidence concerns the gene GPT and Hepatic steatosis.